Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE American:RNN)

2.32
Delayed Data
As of 4:00pm ET
 +0.19 / +8.92%
Today’s Change
1.27
Today|||52-Week Range
7.10
+63.50%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close2.13
Today’s open2.15
Day’s range2.14 - 2.37
Volume860,272
Average volume (3 months)411,826
Market cap$67.6M
Dividend yield--
Data as of 4:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-157.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.96

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc+0.02+0.94%
EIGREiger BioPharmaceuti...-0.10-0.90%
NOVNNovan Inc+0.06+1.13%
NBYNovaBay Pharmaceutic...+0.10+2.30%
Data as of 4:00pm ET, 11/24/2017

Financials

Next reporting dateMarch 20, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts